Tengström, Maria <br/><br/>
MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Jun 2014 
 - 769-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2014.892210  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Case-Control Studies<br/>Chemotherapy, Adjuvant<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Genotype<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Superoxide Dismutase--genetics<br/>Tamoxifen--therapeutic use<br/>Xeroderma Pigmentosum Group D Protein--genetics